WuXi Biologics (Cayman) Inc. (2269.HK)
HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
At close: 04:08PM HKT
| Previous Close | 14.560 |
| Open | 14.880 |
| Bid | 13.940 x 0 |
| Ask | 13.960 x 0 |
| Day's Range | 13.520 - 14.920 |
| 52 Week Range | 12.420 - 52.450 |
| Volume | |
| Avg. Volume | 56,294,978 |
| Market Cap | 58.111B |
| Beta (5Y Monthly) | 0.62 |
| PE Ratio (TTM) | 16.82 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Yahoo Finance
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
- South China Morning Post
US lawmaker moves bill to ban Chinese biotech firms from federal contracts, alleging complicity with military
A US lawmaker has proposed a bill to block Chinese biotechnology companies doing business with the US government due to alleged complicity with the Chinese military, broadening the ongoing sanctions in sectors including hi-tech, semiconductors and cotton production over economic, political and human rights issues. China seeks to dominate biotechnology as an industry of the future, and the nation's biotech firms "have repeatedly collaborated with PLA [the People's Liberation Army] entities" with
© 2024 Yahoo. All rights reserved.